Follow-The-Filings

Security · featured owners

DYN Dyne Therapeutics Inc.

Health Care COM Equity as of 2026 Q2 among managers we track

  • 1 Owner
  • Max 5.1%
  • $37M
  • 1 reduce 1 exit

DYN (Dyne Therapeutics Inc.) is held in 1 featured 13F book as of 2026 Q2. Palo Alto Investors is the largest tracked holder by portfolio weight (5.1%). Figures are as-filed 13F, not free float.

Who owns this now

Largest portfolio weights among featured holders · max 5.1% (Palo Alto Investors) · not free-float ownership

  1. Palo Alto Investors reduce 5.1%

holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

history
Palo Alto Investors 2026 Q2 5.1% Reduce −0.3% 1,647,521 $37M history
Farallon Capital Management exited 2026 Q2 last 2026 Q1 <0.01% Exit 0.00% 10,000 $181K history

1 current · 1 exited last period · options excluded

SEC filings

Recent issuer filings from EDGAR · 10 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 1.01,8.01,9.01 Filing Doc
424B5 Filing Doc
424B5 Filing Doc
8-K 8.01 Filing Doc
8-K 5.02 Filing Doc
8-K 1.01,2.03 Filing Doc
8-K 5.07 Filing Doc
8-K 7.01,8.01,9.01 Filing Doc

Insider forms

Form 3 / 4 / 5 from EDGAR · 13 rows shown

Filed Form Detail Links
4 Period Sep 8, 2026 Filing Doc
4 Period Sep 4, 2026 · 2 forms Filing Doc
4 Period Aug 13, 2026 · 5 forms Filing Doc
4 Period Jul 27, 2026 Filing Doc
4 Period Jul 6, 2026 Filing Doc
4 Period Jun 26, 2026 Filing Doc
4 Period Jun 23, 2026 Filing Doc
4 Period Jun 25, 2026 Filing Doc
4 Period Jun 22, 2026 Filing Doc
4 Period Jun 22, 2026 Filing Doc
4 Period Jun 17, 2026 Filing Doc
4 Period Jun 16, 2026 · 3 forms Filing Doc
4 Period Jun 5, 2026 · 6 forms Filing Doc

Updated 6 days ago Source: SEC EDGAR submissions All on EDGAR

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Net income -$235.94M -$317.42M -$446.21M

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $0.129B $0.659B $1.13B
Total non-current assets * $35.71M $31.96M $31.2M
Total assets $0.165B $0.691B $1.19B
Total current liabilities $51.1M $42.26M $50.62M
Total non-current liabilities * $22.7M $19.14M $164.2M
Total equity $91.29M $629.84M $972.13M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$188.16M -$292.37M -$403.21M
Cash from investing $83.31M -$204.08M -$28.75M
Cash from financing $54.32M $809.9M $890.31M
Net change in cash -$50.52M $313.45M $458.35M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders